Experimental vaccine trains body to fight kidney cancer
NCT ID NCT00625755
First seen Jan 24, 2026 · Last updated May 19, 2026 · Updated 11 times
Summary
This study tested a personalized vaccine made by fusing a patient's own tumor cells with immune-stimulating cells from a healthy donor. The goal was to see if these injections are safe and can help the immune system attack advanced kidney cancer. 40 adults with stage IV kidney cancer participated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
BIDMC
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.